MedCore: Global Hybrid Operating Room Imaging System Market Size, Share, and Trends Analysis | 2024-2030

Hybrid Operating Room Imaging System Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedCore

Product Description:

In 2023, the global market for hybrid operating room (OR) imaging systems reached a value of nearly $1.5 billion. Forecasts project a robust growth trajectory, with a Compound Annual Growth Rate (CAGR) of 17.9%, aiming to achieve $4.7 billion during the forecast period.

This comprehensive medical market research involved the analysis of over 5 hybrid OR imaging system companies spanning 7 continents. Utilizing our thorough methodology, we examined market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite on the global market for hybrid operating rooms (ORs) imaging systems encompasses the sales of imaging equipment.

DATA TYPES INCLUDED:

Unit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2030, and Historical Data to 2020
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions

COVID19 Impact

Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Hybrid OR Imaging System Market Insights:

Initially tailored for vascular and cardiac procedures, hybrid operating rooms have undergone a transformation, now including orthopedics and a diverse array of general procedures that leverage image-guided surgery. This evolution markedly improves the adaptability of these rooms, enabling them to efficiently accommodate a broader spectrum of medical procedures. As image-guided techniques continue to gain prevalence in the field of medicine, the demand for imaging systems within operating rooms is expected to rise accordingly.

Global Hybrid OR Imaging System Market Share Insights:

As of 2023, Siemens secured the leading position in the hybrid operating room (OR) imaging system market with its Artis® line. Notably, the Artis pheno® stood out for its advanced features, including a highly flexible robotic arm-mounted C-arm, allowing for precise control in minimally invasive procedures. Siemens' provision of various configurations catered to facilities of all sizes, contributing to its substantial market share.
Following closely, Phillips made its mark with the Azurion® line, renowned for integrated image-guided systems that drive workflow innovation within hybrid OR setups.
In the third position, GE Healthcare offered the Discovery® IGS 730 and 740 systems, excelling in high-end fluoroscopy image guidance across diverse surgical procedures. Additionally, their Innova® IGS 540 system served as an option for interventional radiology in hybrid ORs, although it didn't gain as much popularity as their other offerings.

Market Segmentation Summary:

Global Hybrid OR Imaging System Market

Global Research Scope Summary:

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2023

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.